bio-europe 2019

BCI Pharma will attend great strategic discussions on its neuropathic pain project.

BCI Pharma has been invited to give a lecture during the pain session at the EFMC symposium in Krakow (Poland). Great in vivo efficacy data will be presented.

BCI Pharma will participate in the 7th International Congress on Neuropathic pain in London (United Kingdom) and will be presented their research programs on this field.

BCI Pharma is proud to announce that the company set up a scientific advisor board with experts in neuropathic pain (G. Skouteris and F. Bernhard) and translational function (M. Martiens – Toxicology, G. Mueller – Kinase research).